The sponsor is always accountable.

The sponsor is always accountable.

Whether activities are performed internally or delegated, the sponsor remains responsible for the quality, integrity, safety, oversight, and regulatory compliance of the clinical trial.

FDA inspection: you answer. You’re accountable.

• CRO — Delegated execution — Execution risk
• Clinical sites — Patient care — Site performance risk
• Central labs — Data & results — Data quality risk
• Safety — Patient safety — Safety signals
• Data management — Data integrity — Data integrity risk
• eTMF / Documentation — Record compliance — Documentation gaps
• Statistics — Analysis & reporting — Analysis / timeline risk
• Medical writing — Regulatory documents — Documentation / submission risk
• Regulatory — Compliance & submissions — Submission risk

Request a Clinical Execution Assessment — Identify gaps. Understand exposure. Strengthen oversight. Confidential. Secure. Trusted.

Delegation transfers activities. It never transfers accountability.

Executive visibility: See what matters. · Execution alignment: Identify critical gaps. · Inspection exposure: Identify potential regulatory inspection issues. · Regulatory risk visibility: See exposure early. · Informed decision-making: Decide from evidence.